These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10722523)

  • 1. Effect of fluconazole on the pharmacokinetics of doxorubicin in nonhuman primates.
    Warren KE; McCully CM; Walsh TJ; Balis FM
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1100-1. PubMed ID: 10722523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluconazole on the pharmacokinetics and pharmacodynamics of oral and rectal bromazepam: an application of electroencephalography as the pharmacodynamic method.
    Ohtani Y; Kotegawa T; Tsutsumi K; Morimoto T; Hirose Y; Nakano S
    J Clin Pharmacol; 2002 Feb; 42(2):183-91. PubMed ID: 11831541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers.
    Kang BC; Yang CQ; Cho HK; Suh OK; Shin WG
    Biopharm Drug Dispos; 2002 Mar; 23(2):77-81. PubMed ID: 11932962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.
    Panomvana Na Ayudhya D; Thanompuangseree N; Tansuphaswadikul S
    Clin Pharmacokinet; 2004; 43(11):725-32. PubMed ID: 15301576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
    Saari TI; Laine K; Neuvonen M; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2008 Jan; 64(1):25-30. PubMed ID: 17987285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters.
    Alnaim L; Abou Alsoud N; Zaghloul I; Al-Jaser M
    Int J Antimicrob Agents; 2007 Jun; 29(6):728-32. PubMed ID: 17369029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fluconazole on the clinical pharmacokinetics of methadone.
    Cobb MN; Desai J; Brown LS; Zannikos PN; Rainey PM
    Clin Pharmacol Ther; 1998 Jun; 63(6):655-62. PubMed ID: 9663180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cellular pharmacokinetics of doxorubicin after intravenous infusion of Caelyx/Doxil in patients with hematological tumors.
    Richly H; Grubert M; Scheulen ME; Hilger RA
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):55-7. PubMed ID: 19203539
    [No Abstract]   [Full Text] [Related]  

  • 9. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats.
    Behnia K; Boroujerdi M
    J Pharm Pharmacol; 1999 Nov; 51(11):1275-82. PubMed ID: 10632085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
    Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Vyyryläinen H; Laine K
    Antimicrob Agents Chemother; 2006 Jun; 50(6):1967-72. PubMed ID: 16723553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
    Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
    Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
    [No Abstract]   [Full Text] [Related]  

  • 15. Voriconazole and fluconazole increase the exposure to oral diazepam.
    Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies.
    Greenblatt DJ; von Moltke LL; Perloff ES; Luo Y; Harmatz JS; Zinny MA
    Clin Pharmacol Ther; 2006 Jan; 79(1):125-33. PubMed ID: 16413247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole in cats: pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid.
    Vaden SL; Heit MC; Hawkins EC; Manaugh C; Riviere JE
    J Vet Pharmacol Ther; 1997 Jun; 20(3):181-6. PubMed ID: 9185083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.
    Dobbs NA; Twelves CJ; Gillies H; James CA; Harper PG; Rubens RD
    Cancer Chemother Pharmacol; 1995; 36(6):473-6. PubMed ID: 7554038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats.
    Nagai K; Nogami S; Egusa H; Konishi H
    Pharmazie; 2014 Feb; 69(2):125-7. PubMed ID: 24640601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
    Wittenburg LA; Weishaar K; Ramirez D; Gustafson DL
    Vet Comp Oncol; 2019 Jun; 17(2):147-154. PubMed ID: 30638304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.